Sastasundar Ventures
303.85
0.00(0.00%)
Market Cap₹966.56 Cr
PE Ratio-105.35
Company Performance:
1D0.00%
1M-4.82%
6M+3.28%
1Y-9.05%
5Y+160.26%
View Company Insightsright
More news about Sastasundar Ventures
16Aug 25
SastaSundar Ventures Reports Mixed Q1 Results: B2B Growth Offsets B2C Decline
Sastasundar Ventures Limited reported a 5.9% YoY increase in total revenue to ₹278.50 crores for Q1. The B2B segment, RetailerShakti, grew by 30.9% to ₹244.50 crores, while the B2C segment, SastaSundar, declined by 55.7% to ₹33.30 crores. Financial Services revenue surged 168.9% to ₹19.90 crores. EBITDA was -₹13.80 crores, and PAT decreased by 35.1% to ₹26.60 crores. The company maintains a strong balance sheet with ₹974.40 crores in total assets, including ₹655.00 crores in liquid assets. Working capital management improved with inventory days reducing from 40 to 36 days. However, operating cash flow was negative at -₹17.30 crores, indicating ongoing operational challenges.
12Aug 25
Sastasundar Ventures Reports Robust Q1 Profit, Driven by Strong Healthcare Network Performance
Sastasundar Ventures Limited reported a consolidated net profit of Rs. 2,659.21 crore in Q1, a significant improvement from last year's loss. Total revenue from operations stood at Rs. 298.43 crore. The Healthcare Network segment contributed Rs. 278.54 crore to revenue but reported a loss, while the Financial Services segment generated Rs. 19.89 crore in revenue with a profit. On a standalone basis, the company reported a revenue of Rs. 9.67 lakh and a reduced net loss of Rs. 10.95 lakh. The Board of Directors also reviewed and amended the company's fair disclosure practices code.
30May 25
SASTASUNDAR VENTURES Reports Decline in Q4 Profit and Revenue
SASTASUNDAR VENTURES released its Q4 consolidated financial results, showing a decline in both profit and revenue. Net profit decreased by 16.46% to ₹137.00 crore from ₹164.00 crore in the previous year. Revenue fell by 7.17% to ₹285.00 crore from ₹307.00 crore year-over-year.
Sastasundar Ventures
303.85
0.0
(0.0%)
1 Year Returns:-9.05%
Industry Peers
Dr. Lal Path Labs
1,391.60
(-50.19%)
Metropolis Healthcare
1,885.80
(+0.88%)
Krsnaa Diagnostics
718.95
(+0.45%)
Suraksha Diagnostic
272.95
(-0.07%)
3B BlackBio DX
1,388.00
(+2.32%)